Assessment of multimodality therapy use for extremity sarcoma in the United States

Journal of Surgical Oncology

Volumn 109, Issue 5, 2014, Pages 395-404

  Sherman, Karen L ^a   Wayne, Jeffrey D ^a   Chung, Jeanette ^a   Agulnik, Mark ^a   Attar, Samer ^a   Hayes, John P ^a   Laskin, William B ^a   Peabody, Terrance D ^a   Bentrem, David J ^a,b   Pollock, Raphael E ^c   Bilimoria, Karl Y ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

cancer; chemotherapy; neoadjuvant; radiation; soft tissue

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURGERY; COMORBIDITY; DATA BASE; FEMALE; HOSPITAL; HUMAN; LIMB TUMOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT RESPONSE; UNITED STATES;

CANCER; CHEMOTHERAPY; NEOADJUVANT; RADIATION; SOFT TISSUE;

ACADEMIC MEDICAL CENTERS; ADULT; AGE FACTORS; AGED; AMPUTATION; CHEMOTHERAPY, ADJUVANT; DATABASES, FACTUAL; EXTREMITIES; FEMALE; FIBROSARCOMA; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; INSURANCE, HEALTH; LEIOMYOSARCOMA; LIMB SALVAGE; LIPOSARCOMA; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; RADIOTHERAPY, ADJUVANT; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SARCOMA; SARCOMA, SYNOVIAL; UNITED STATES;

EID: 84897021858     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23520     Document Type: Article

References (33)

1. Siegel R, Naishadham D, Jemal A:, Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Demetri GD, Baker LH, Beech D, et al.: Soft tissue sarcoma clinical practice guidelines in oncology. J Natl Compr Canc Netw 2005; 3: 158-194.
3. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 1997; 350: 1647-1654.
4. Pervaiz N, Colterjohn N, Farrokhyar F, et al.: A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008; 113: 573-581.
5. Pollock RE, Karnell LH, Menck HR, et al.: The National Cancer Data Base report on soft tissue sarcoma. Cancer 1996; 78: 2247-2257.
6. Bilimoria KY, Stewart AK, Winchester DP, et al.: The National Cancer Data Base: A powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2008; 15: 683-690.
7. American College of Surgeons: About Accreditation. 2013. Available at: http://www.facs.org/cancer/coc/whatis.html
8. American College of Surgeons: Facility Oncology Registry Data Standards 2013. Available at: http://www.facs.org/cancer/coc/fordsmanual.html
9. Percy C, Fritz A, Jack A, et al.: International classification of disease for oncology, 3rd edition. Geneva, Switzerland: World Health Organization; 2000.
10. Deyo RA, Cherkin DC, Ciol MA:, Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
11. Charlson ME, Pompei P, Ales KL, et al.: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.
12. Hermanek P, Wittekind C:, Residual tumor (R) classification and prognosis. Sem Surg Oncol 1994; 10: 12-20.
13. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Soft Tissue Sarcoma. 2012. Available at: www.nccn.org/professionals/physician-gls/pdf/sarcoma.pdf
14. O'Sullivan B, Davis AM, Turcotte R, et al.: Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial. Lancet 2002; 359: 2235-2241.
15. Cheng EY, Dusenbery KE, Winters MR, et al.: Soft tissue sarcomas: Preoperative versus postoperative radiotherapy. J Surg Oncol 1996; 61: 90-99.
16. Kuklo TR, Temple HT, Owens BD, et al.: Preoperative versus postoperative radiation therapy for soft-tissue sarcomas. Am J Orthoped 2005; 34: 75-80.
17. Zagars GK, Ballo MT, Pisters PW, et al.: Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: A retrospective comparative evaluation of disease outcome. Int J Radiat Oncol 2003; 56: 482-488.
18. Tseng JF, Ballo MT, Langstein HN, et al.: The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol 2006; 13: 1209-1215.
19. Vasileios KA, Eward WC, Brigman BE:, Surgical treatment and prognosis in patients with high-grade soft tissue malignant fibrous histiocytoma of the extremities. Arch Orthop Trauma Surg 2012; 132: 955-961.
20. Alamanda VK, Crosby SN, Archer KR, et al.: Amputation for extremity soft tissue sarcoma does not increase overall survival: A retrospective cohort study. Eur J Surg Oncol 2012; 38: 1178-1183.
21. Mundt AJ, Awan A, Sibley GS, et al.: Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: Clinical and radiobiological results. Int J Radiat Oncol 1995; 32: 977-985.
22. Wanebo HJ, Temple WJ, Popp MB, et al.: Preoperative regional therapy for extremity sarcoma. A tricenter update. Cancer 1995; 75: 2299-2306.
23. Wilson AN, Davis A, Bell RS, et al.: Local control of soft tissue sarcoma of the extremity: The experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur J Cancer 1994; 30A: 746-751.
24. Yang JC, Chang AE, Baker AR, et al.: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998; 16: 197-203.
25. Pisters PW, O'Sullivan B, Maki RG:, Evidence-based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol 2007; 25: 1003-1008.
26. Skinner KA, Eilber FR:, Soft tissue sarcoma nodal metastases: Biologic significance and therapeutic considerations. Surg Oncol Clin N Am 1996; 5: 121-127.
27. Eilber FC, Brennan MF, Eilber FR, et al.: Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg 2007; 246: 105-113.
28. Casali PG:, Histology- and non-histology-driven therapy for treatment of soft tissue sarcomas. Ann Oncol 2012; 23: x167-x169.
29. Alamanda VK, Crosby SN, Archer KR, et al.: Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma. Acta Oncol 2013; 52: 793-802.
30. Sherman KL, Merkow RP, Bilimoria KY, et al.: Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States. Ann Surg Oncol 2013; 20: 362-370.
31. Wasif N, Smith CA, Tamurian RM, et al.: Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremities. JAMA Surg 2013; 1-8.
32. Cress RD, Zaslavsky AM, West DW, et al.: Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care 2003; 41: 1006-1012.
33. Du XL, Key CR, Dickie L, et al.: Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews. J Clin Epidemiol 2006; 59: 53-60.